These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis. Thongboonkerd V; Lumlertgul D; Supajatura V Artif Organs; 2001 Feb; 25(2):99-108. PubMed ID: 11251475 [TBL] [Abstract][Full Text] [Related]
9. Use of different buffers in peritoneal dialysis. Feriani M Semin Dial; 2000; 13(4):256-60. PubMed ID: 10923355 [TBL] [Abstract][Full Text] [Related]
10. Are current peritoneal dialysis solutions adequate for pediatric use? Verrina EE; Cannavò R; Schaefer B; Schmitt CP Contrib Nephrol; 2012; 178():16-22. PubMed ID: 22652710 [TBL] [Abstract][Full Text] [Related]
11. The effect of bicarbonate peritoneal dialysis solutions on cardiac structural and functional alterations. Theodoridis M; Tziakas D; Passadakis P; Kantartzi K; Roumeliotis A; Thodis E; Vargemezis V Nephrol Dial Transplant; 2011 Dec; 26(12):4061-7. PubMed ID: 21543656 [TBL] [Abstract][Full Text] [Related]
12. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741 [TBL] [Abstract][Full Text] [Related]
13. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742 [TBL] [Abstract][Full Text] [Related]
14. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882 [TBL] [Abstract][Full Text] [Related]
16. Effects of customized bicarbonate buffered solutions for continuous renal replacement therapies on polymorphonuclear leukocytes function and viability. Maccariello E; Dalboni MA; Draibe SA; Rocha E; Pavão dos Santos OF; Santos B; Cendoroglo M Artif Organs; 2004 Jun; 28(6):571-6. PubMed ID: 15153150 [TBL] [Abstract][Full Text] [Related]
17. On the usefulness of glycylglycine in hemodialysis and peritoneal dialysis solutions. Yatzidis H; Dombros NV; Digenis GE ASAIO J; 1996; 42(6):984-92. PubMed ID: 8959273 [TBL] [Abstract][Full Text] [Related]
18. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794 [TBL] [Abstract][Full Text] [Related]
19. Use of bicarbonate/lactate-buffered dialysate with a nighttime cycler, associated with a daytime dwell with icodextrin, may result in alkalosis in children. Vande Walle JG; Raes AM; Dehoorne J; Mauel R Adv Perit Dial; 2004; 20():222-5. PubMed ID: 15384831 [TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor, fibroblast growth factor, and lactate dehydrogenase by human peritoneal mesothelial cells in solutions with lactate or bicarbonate or both. Ogata S; Mori M; Tatsukawa Y; Kiribayashi K; Yorioka N Adv Perit Dial; 2006; 22():37-40. PubMed ID: 16983936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]